iNova Pharmaceuticals Executive and Leadership Team

Paul Smith, the Chief Operating Officer at iNova Pharmaceuticals, directs all internal supply chain logistics and manufacturing workflows. Overseeing the production of prescription medicines, the Chief Operating Officer ensures that quality standards remain consistent across all international facilities. This leadership role involves optimizing resource allocation to support the distribution of consumer health products throughout Australia and New Zealand. By streamlining operational processes, Paul Smith directly impacts the efficiency of the entire organization. Smith manages the integration of new manufacturing technologies to maintain a competitive edge in the pharmaceutical sector. Furthermore, the Chief Operating Officer coordinates with regional leads to align production schedules with market demand. Through rigorous oversight of operational infrastructure, Smith secures the long-term stability of the supply chain, ensuring that essential health products reach patients across the diverse geographic footprint of the company.

Andrew Jenkin, the President, , Zealand, & At Inova Pharmaceuticals (Australia, Canada, South Africa) at iNova Pharmaceuticals, directs the commercial strategy across key international territories. Overseeing market expansion, the President, , Zealand, & At Inova Pharmaceuticals (Australia, Canada, South Africa) ensures that prescription and consumer health products reach target demographics effectively. This leadership role involves managing complex regulatory environments and driving revenue growth within the Australian, Canadian, and South African markets. By analyzing regional health trends, Andrew Jenkin directly impacts the strategic positioning of the company. Jenkin coordinates with local sales teams to optimize product availability and brand visibility. Furthermore, the President, , Zealand, & At Inova Pharmaceuticals (Australia, Canada, South Africa) evaluates competitive landscapes to identify new opportunities for portfolio growth. Through the execution of targeted commercial initiatives, Jenkin secures a strong market presence, ensuring that the organization remains a leader in providing essential medicines to diverse patient populations.

Sacha Ernst, the President (Asia) at iNova Pharmaceuticals, directs all business development and commercial operations throughout the Asian market. Overseeing regional growth, the President (Asia) ensures that the distribution of prescription medicines and consumer health products meets the specific needs of local healthcare systems. This leadership role involves building strategic partnerships and navigating the unique regulatory requirements across various Asian countries. By identifying emerging market opportunities, Sacha Ernst directly impacts the expansion of the company footprint. Ernst manages the alignment of regional sales strategies with the overarching corporate objectives. Furthermore, the President (Asia) collaborates with cross-functional teams to adapt product offerings to regional preferences. Through the implementation of localized marketing and distribution plans, Ernst secures a competitive advantage, ensuring that the organization effectively serves the growing demand for high-quality pharmaceutical products across the entire Asian region.

Yee Goh, the Chief People Officer at iNova Pharmaceuticals, architects the global talent strategy and organizational culture. Overseeing human capital initiatives, the Chief People Officer ensures that recruitment and retention programs align with the broader mission of delivering high-quality healthcare solutions. This leadership role involves fostering an inclusive environment that supports professional development across the diverse workforce in Asia, Africa, and Australia. By implementing performance management systems, Yee Goh directly impacts employee engagement and operational productivity. Goh manages the alignment of corporate values with daily business practices to drive organizational excellence. Furthermore, the Chief People Officer collaborates with executive leadership to design compensation structures that attract top-tier industry talent. Through the continuous refinement of internal policies, Goh secures a high-performing culture, ensuring that the organization maintains the human expertise necessary to navigate the complexities of the international pharmaceutical market.